Arrivent Biopharma Inc
NASDAQ:AVBP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Arrivent Biopharma Inc
NASDAQ:AVBP
|
US |
|
H
|
HLS Therapeutics Inc
OTC:HLTRF
|
CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
CA |
|
M
|
Markel Group Inc
SWB:MKV
|
US |
|
Socialwire Co Ltd
TSE:3929
|
JP |
|
Reply SpA
MIL:REY
|
IT |
|
G
|
Guardian Capital Group Ltd
OTC:GCAAF
|
CA |
|
ZoomInfo Technologies Inc
NASDAQ:GTM
|
US |
|
Fortune Rise Acquisition Corp
NASDAQ:FRLA
|
US |
Wall Street
Price Targets
AVBP Price Targets Summary
Arrivent Biopharma Inc
According to Wall Street analysts, the average 1-year price target for AVBP is 43.58 USD with a low forecast of 33.33 USD and a high forecast of 52.5 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AVBP's stock price target?
Price Target
43.58
USD
According to Wall Street analysts, the average 1-year price target for AVBP is 43.58 USD with a low forecast of 33.33 USD and a high forecast of 52.5 USD.